Journal of Liver

Bioactive compounds from rainbow trout waste and liver cell recovery

Lavinia Carrera^* Department of Liver and Metabolic Diseases, University of Granada, Granada, Spain
^*Correspondence: Lavinia Carrera, Department of Liver and Metabolic Diseases, University of Granada, Granada, Spain, Email:

Received: 29-Aug-2025, Manuscript No. JLR-25-30449; Editor assigned: 01-Sep-2025, Pre QC No. JLR-25-30449 (PQ); Reviewed: 15-Sep-2025, QC No. JLR-25-30449; Revised: 22-Sep-2025, Manuscript No. JLR-25-30449 (R); Published: 29-Sep-2025, DOI: 10.35248/2167-0889.25.14.263

Description

Alcohol misuse remains one of the most persistent contributors to liver injury worldwide. While the consequences of chronic alcohol intake range from steatosis to cirrhosis and hepatocellular carcinoma, the earliest damage often occurs at the cellular level through oxidative imbalance and disrupted autophagic processes within hepatocytes. These changes alter redox homeostasis, resulting in lipid peroxidation, protein modification, DNA damage, and inflammatory activation. Recent experimental attention has shifted toward bioactive compounds derived from natural and sustainable sources. Among these, protein hydrolysates obtained from rainbow trout by-products have shown notable potential to counter alcoholinduced oxidative stress while restoring normal autophagic function in hepatocytes.

The search for natural bioactive agents capable of reducing oxidative damage and restoring autophagic balance has expanded in recent years. Fish processing by-products, often regarded as waste, contain considerable amounts of high-quality proteins with biologically active peptide sequences. Rainbow trout, widely cultivated for food, generates substantial residual material such as heads, skin, bones, and viscera. Through enzymatic hydrolysis, these residual materials can be transformed into low molecular weight peptides known as protein hydrolysates. These peptides exhibit antioxidant, antiinflammatory, and cytoprotective activities owing to their amino acid composition, particularly the presence of histidine, cysteine, methionine, proline, and hydrophobic residues.

At the level of mitochondrial preservation, these hydrolysates stabilize membrane potential and restore the function of electron transport chain complexes that are often compromised by prolonged alcohol exposure. By reducing mitochondrial swelling and preventing cytochrome c release, cell death mechanisms such as apoptosis are diminished. This leads to improved hepatocyte viability and reduced release of liver enzymes into circulation, which are commonly used as biomarkers of liver injury. Aminotransferases such as ALT and AST are significantly lower in subjects receiving these peptide compounds, indicating reduced hepatocellular damage.

The molecular composition of these hydrolysates plays a key role in their protective activity. Peptides rich in hydrophobic and aromatic amino acids interact with membrane lipids, providing stability and limiting peroxidation. Meanwhile, peptides containing sulfur-containing residues contribute to the regeneration of reduced glutathione, one of the most important intracellular antioxidants. In addition, certain di- and tripeptides formed during hydrolysis have been shown to influence kinase signaling pathways that regulate autophagy and oxidative defense.

The use of fish by-products represents not only a biomedical strategy but also an environmentally responsible approach. Large quantities of waste generated by fish processing industries contribute to pollution and resource inefficiency. Converting these remnants into functional therapeutic compounds aligns with sustainable principles while supporting circular economy models. It provides value addition to an otherwise underutilized resource and promotes ethical use of marine materials.

The application of rainbow trout protein hydrolysates can be envisioned in the form of dietary supplements, functional foods, or as supportive co-therapies alongside conventional interventions for individuals at risk of alcohol-related liver injury. These peptides offer a natural alternative with minimal side effects when appropriately processed and purified. Further research in human clinical settings may establish standardized dosages and long-term outcomes, but existing experimental evidence strongly supports their protective capabilities.

Beyond alcoholic liver disease, these hydrolysates may potentially benefit other metabolic disorders associated with oxidative imbalance and defective autophagy, including non-alcoholic fatty liver disease, insulin resistance, and age-related cellular degeneration. Their broad-spectrum antioxidant and regulatory properties make them highly adaptable for multiple therapeutic contexts. While the precise peptide sequences responsible for these effects are under continued investigation, current findings demonstrate that even crude hydrolysate mixtures exhibit consistent activity.

It is also worth considering the bioavailability of these peptides. Due to their low molecular weight, they are readily absorbed across the intestinal epithelium and can reach hepatic tissue through portal circulation. Once in the liver, they interact directly with hepatocytes and resident immune cells, exerting both immediate and long-term effects. Their compatibility with the human digestive system makes them suitable for oral administration without extensive formulation requirements.

In conclusion, alcohol-induced oxidative stress and disturbed autophagy represent major mechanisms underlying liver injury. The ability of protein hydrolysates derived from rainbow trout by-products to neutralize free radicals, restore antioxidant capacity, regulate autophagic processes, reduce inflammation, and rebalance lipid metabolism positions them as a valuable therapeutic agent. This approach demonstrates how natural marine-derived compounds can contribute to liver health by addressing fundamental cellular disturbances caused by prolonged alcohol exposure. Continued exploration of these biologically active peptides may lead to innovative interventions that safeguard liver function while simultaneously promoting sustainability and resource efficiency.